MTOR and central nervous system cancer: in xenograft glioma mouse models show that presynaptic and postsynaptic function is disrupted in the presence of glioma with microenvironmental neurolignin 3 (NLGN3) being hijacked to induce signaling through the PI3K/PTEN/AKT/mTOR pathway (55).